Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
October, 2026
October 2026
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Richa Sharma Shares ARCADIA Post-Hoc Findings: Apixaban Prevents Recurrent Stroke in ESUS Patients with LV Dysfunction
Richa Sharma/X
Sep 3, 2025, 12:48

Richa Sharma Shares ARCADIA Post-Hoc Findings: Apixaban Prevents Recurrent Stroke in ESUS Patients with LV Dysfunction

Richa Sharma, Associate Professor of Neurology at Yale School of Medicine, has shared a post on X:

“Lower risk of recurrent stroke among patients with ESUS and left ventricular dysfunction randomized to apixaban in the ARCADIA trial in our post-hoc analysis.”

Title: Lower risk of recurrent stroke among patients with ESUS and left ventricular dysfunction randomized to apixaban in the ARCADIA trial in our post-hoc analysis.

Authors: Richa Sharma, Dinesh Jillella, Cenai Zhang, Mitchell S.V. Elkind, Hooman Kamel, Marco R. Di Tullio, Richard A. Kronmal, Balaji Krishnaiah, Shadi Yaghi, W.T. Longstreth Jr, David Tirschwell, Alexander Merkler, Fadi Nahab

Apixaban

Read the full article here.

Find similar posts on Hemostasis Today.

Alexander Merkler Apixaban ARCADIA trial Balaji Krishnaiah Cenai Zhang David Tirschwell Dinesh Jillella Fadi Nahab Hematology Hemostasis Hemostasis Today Hooman Kamel Marco R. Di Tullio Mitchell S.V. Elkind recurrent stroke Richa Sharma Richard A. Kronmal Shadi Yaghi W.T. Longstreth Jr
NewsFeed